We serve Chemical Name:3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol CAS:182057-85-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol
CAS.NO:182057-85-8
Synonyms:3-amino-3-(4-benzyloxy-phenyl)-propan-1-ol;aminobenzyloxyphenylpropanol;DL-A-(4-Benzyloxyphenyl)alaninol;DL-(4-Benzyloxyphenyl)alaninol
Molecular Formula:C16H19NO2
Molecular Weight:257.32800
HS Code:2922509090
Physical and Chemical Properties:
Melting point:106-108ºC
Boiling point:442ºC at 760mmHg
Density:1.141g/cm3
Index of Refraction:1.595
PSA:55.48000
Exact Mass:257.14200
LogP:3.34810
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-amino-3-(4-benzyloxy-phenyl)-propan-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DL-(4-Benzyloxyphenyl)alaninol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,DL-(4-Benzyloxyphenyl)alaninol Use and application,3-amino-3-(4-benzyloxy-phenyl)-propan-1-ol technical grade,usp/ep/jp grade.
Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development. 3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol manufacturer Unfortunately, PFAS are considered forever chemicals” because they don’t naturally degrade, Bruton said. Instead, they accumulate in the bodies of humans and animals. It’s believed that every single American has a detectable level of PFAS in their bodies.
Some PFAS chemicals have been shown to be toxic, potentially contributing to high cholesterol levels, low infant birth weights, immune deficiencies and thyroid gland disruptions, according to the EPA.
“The problem with these chemicals is they last a long time in the environment as well as in your body,” said Dr. Maaike van Gerwen, an assistant professor in the Institute of Translational Epidemiology at Mount Sinai in New York City. “We do not know exactly what the harm is of exposure to very low levels of these chemicals over a very long period of time, because these are a relatively new kind of chemical. 3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol supplier Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets. 3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol vendor Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets. 3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol factory Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.
Some PFAS chemicals have been shown to be toxic, potentially contributing to high cholesterol levels, low infant birth weights, immune deficiencies and thyroid gland disruptions, according to the EPA.
“The problem with these chemicals is they last a long time in the environment as well as in your body,” said Dr. Maaike van Gerwen, an assistant professor in the Institute of Translational Epidemiology at Mount Sinai in New York City. “We do not know exactly what the harm is of exposure to very low levels of these chemicals over a very long period of time, because these are a relatively new kind of chemical. 3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol supplier Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets. 3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol vendor Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets. 3-amino-3-(4-phenylmethoxyphenyl)propan-1-ol factory Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.
